Prevention of iatrogenic acute narrow-angle glaucoma.
The pathophysiology of glaucoma is reviewed, and the risks of pharmacologic pupillary dilation are discussed. A simple transillumination screening test for identifying patients in whom mydriasis presents a risk is described.
D005123:Eye / Q000033:anatomy & histology; D005901:Glaucoma / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009184:Mydriatics / Q000009:adverse effects*; D014172:Transillumination
D009184:Mydriatics